BRPI0517413A - composições farmacêuticas com gosto mascarado - Google Patents

composições farmacêuticas com gosto mascarado

Info

Publication number
BRPI0517413A
BRPI0517413A BRPI0517413-9A BRPI0517413A BRPI0517413A BR PI0517413 A BRPI0517413 A BR PI0517413A BR PI0517413 A BRPI0517413 A BR PI0517413A BR PI0517413 A BRPI0517413 A BR PI0517413A
Authority
BR
Brazil
Prior art keywords
suspension
ready
pharmaceutical compositions
active substance
masked taste
Prior art date
Application number
BRPI0517413-9A
Other languages
English (en)
Inventor
Franz Xaver Schwarz
Irina Kosilek
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33443791&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0517413(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of BRPI0517413A publication Critical patent/BRPI0517413A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

COMPOSIçõES FARMACêUTICAS COM GOSTO MASCARADO. A presente invenção refere-se a uma composição farmacêutica para administração oral adequada para a preparação de uma suspensão pronta para uso compreendendo partículas revestidas compreendendo uma substância ativa que tem um gosto desagradável e/ou amargo, tal como a claritromicina, e uma base de suspensão compreendendo uma substância osmoticamente ativa capaz de fornecer uma alta osmolalidade à mistura da base de suspensão com um meio aquoso para suspensão, na suspensão pronta para uso. A dita suspensão pronta para uso mantém a sua palatabilidade durante um prolongado período de tempo devido àquelas condições osmóticas definidas.
BRPI0517413-9A 2004-10-12 2005-10-10 composições farmacêuticas com gosto mascarado BRPI0517413A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0422645A GB2419094A (en) 2004-10-12 2004-10-12 Pharmaceutical composition of unpleasnt tasing active substances
PCT/EP2005/010890 WO2006040112A2 (en) 2004-10-12 2005-10-10 Taste-masking pharmaceutical compositions

Publications (1)

Publication Number Publication Date
BRPI0517413A true BRPI0517413A (pt) 2008-10-07

Family

ID=33443791

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0517413-9A BRPI0517413A (pt) 2004-10-12 2005-10-10 composições farmacêuticas com gosto mascarado

Country Status (14)

Country Link
US (1) US7767231B2 (pt)
EP (1) EP1802275B1 (pt)
JP (1) JP5134961B2 (pt)
CN (1) CN101083977B (pt)
AR (1) AR053977A1 (pt)
AU (1) AU2005293800B2 (pt)
BR (1) BRPI0517413A (pt)
CA (1) CA2581493C (pt)
ES (1) ES2514468T3 (pt)
GB (1) GB2419094A (pt)
RU (1) RU2399370C2 (pt)
SI (1) SI1802275T1 (pt)
WO (1) WO2006040112A2 (pt)
ZA (1) ZA200702418B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5132090B2 (ja) * 2006-06-16 2013-01-30 東和薬品株式会社 塩酸エピナスチンドライシロップ剤
WO2010010568A1 (en) * 2008-07-22 2010-01-28 Lupin Limited Oral compositions of clindamycin
US9504274B2 (en) * 2009-01-27 2016-11-29 Frito-Lay North America, Inc. Methods of flavor encapsulation and matrix-assisted concentration of aqueous foods and products produced therefrom
MY172424A (en) * 2009-04-03 2019-11-25 Hoffmann La Roche Propane- i-sulfonic acid {3- (4-chloro-phenyl)-1h-pyrrolo [2, 3-b] pyridine-3-carconyl] -2, 4-difluoro-phenyl} -amide compositions and uses thereof
CN101879141B (zh) * 2009-05-05 2013-07-17 烟台绿叶动物保健品有限公司 一种掩味替米考星胃溶颗粒制剂
MX2016014320A (es) 2014-05-01 2017-05-23 Sun Pharmaceutical Ind Ltd Composiciones de suspension de liberacion prolongada.
US9962336B2 (en) * 2014-05-01 2018-05-08 Sun Pharmaceutical Industries Limited Extended release suspension compositions
US20160317388A1 (en) * 2014-05-01 2016-11-03 Sun Pharmaceutical Industries Limited Dual-chamber pack for extended release suspension compositions
US20180104197A9 (en) 2014-05-01 2018-04-19 Sun Pharmaceutical Industries Limited Extended release liquid compositions of metformin
US10258583B2 (en) 2014-05-01 2019-04-16 Sun Pharmaceutical Industries Limited Extended release liquid compositions of guanfacine
BR112017001968A2 (pt) 2014-07-30 2017-11-21 Sun Pharmaceutical Ind Ltd embalagem de duas câmaras para uma composição farmacêutica líquida oral de múltiplas doses
US10238803B2 (en) 2016-05-02 2019-03-26 Sun Pharmaceutical Industries Limited Drug delivery device for pharmaceutical compositions
US10369078B2 (en) 2016-05-02 2019-08-06 Sun Pharmaceutical Industries Limited Dual-chamber pack for pharmaceutical compositions
MX2020006905A (es) * 2018-01-03 2020-09-09 Ferring Bv Composiciones farmaceuticas liquidas orales de aminosalicilatos.
US20220331257A1 (en) * 2019-03-01 2022-10-20 Avadel Legacy Pharmaceuticals, Llc Liquid pharmaceutical compositions with stable drug release profiles
CN115634203B (zh) * 2022-10-28 2024-06-25 南京海纳医药科技股份有限公司 一种含有依巴斯汀的干混悬剂及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3922379A (en) * 1973-12-17 1975-11-25 Abbott Lab Microencapsulation process
US4994260A (en) 1982-05-28 1991-02-19 Astra Lakemedel Aktiebolag Pharmaceutical mixture
NL193682C (nl) 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
US4808411A (en) 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
IT1246383B (it) 1990-04-17 1994-11-18 Eurand Int Metodo per il mascheramento del sapore di farmaci
US5599556A (en) 1991-12-31 1997-02-04 Abbott Laboratories Prolamine coatings for taste masking
IL104093A (en) 1991-12-31 1999-06-20 Abbott Lab Prolamine is expected to mask the taste of drugs given orally
JPH05255073A (ja) * 1992-03-12 1993-10-05 Taisho Pharmaceut Co Ltd 経口製剤およびその製造方法
CA2143439A1 (en) * 1992-09-03 1994-03-17 Seang H. Yiv Taste-masking pharmaceutical compostiions and methods for making the same
CA2172807C (en) * 1994-08-01 1999-10-12 Keith S. Lienhop Tastemasked liquid pharmaceutical delivery system
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
EP0943341A1 (en) 1998-02-18 1999-09-22 Oscar Gold Procedure to prepare granulated compositions that contain erythromycin macrolides and procedure to prepare pharmaceutical compositions that contain said macrolides
ATE248588T1 (de) 1999-06-11 2003-09-15 Ranbaxy Lab Ltd Geschmacksmaskierte zubereitungen
IN191239B (pt) 1999-06-11 2003-10-11 Ranbaxy Lab Ltd
JP2004529178A (ja) * 2001-05-11 2004-09-24 パシフィック・ファーマシューティカルズ・リミテッド 味遮蔽医薬組成物
FR2826274B1 (fr) * 2001-06-21 2003-09-26 Aventis Pharma Sa Formulation pharmaceutique au gout masque et son procede de preparation
OA12625A (en) * 2001-06-22 2006-06-12 Pfizer Prod Inc Pharmaceutical compositions of adsorbates of amorphous drug.
DE10347994A1 (de) * 2003-10-15 2005-06-16 Pari GmbH Spezialisten für effektive Inhalation Wässrige Aerosol-Zubereitung

Also Published As

Publication number Publication date
EP1802275B1 (en) 2014-07-23
ZA200702418B (en) 2009-04-29
CN101083977B (zh) 2013-03-06
AU2005293800A1 (en) 2006-04-20
US20080008765A1 (en) 2008-01-10
JP2008515946A (ja) 2008-05-15
CA2581493A1 (en) 2006-04-20
GB0422645D0 (en) 2004-11-10
JP5134961B2 (ja) 2013-01-30
AR053977A1 (es) 2007-05-30
ES2514468T3 (es) 2014-10-28
CN101083977A (zh) 2007-12-05
AU2005293800B2 (en) 2009-03-26
RU2399370C2 (ru) 2010-09-20
RU2007117499A (ru) 2008-11-20
GB2419094A (en) 2006-04-19
WO2006040112A3 (en) 2007-04-26
CA2581493C (en) 2013-02-19
SI1802275T1 (sl) 2014-11-28
WO2006040112A2 (en) 2006-04-20
EP1802275A2 (en) 2007-07-04
US7767231B2 (en) 2010-08-03

Similar Documents

Publication Publication Date Title
BRPI0517413A (pt) composições farmacêuticas com gosto mascarado
BR0207930A (pt) Composições farmacêuticas lìquidas com sabor mascarado
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
BR0112417A (pt) Composições farmacêuticas contendo composto dds
BRPI0412489A (pt) composição de confeito mastigável liberando para as superfìcies dentárias uma dose unitária de uma enzima
CY1118179T1 (el) Φαρμακευτικη συνθεση
BRPI0509592A (pt) formulações de sabor mascarado, contendo sertralina e ciclodextrina de éter de sulfoalquila
NO20076408L (no) Farmasoytisk preparat som inneholder gestagener og/eller ostrogener og 5-metyl-(6S)-tetrahydrofolat
BR0214806A (pt) Composições farmacêuticos de 5,7,14-triazatetraciclo-{10.3.1.02,11.0,4,9]-hexadeca-2(1 1),3,5,7,9-penteno
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
ATE493973T1 (de) Irbesartan enthaltende pharmazeutische zusammensetzung
BR0109672A (pt) Uso de zd6126 ou de um seu sal farmaceuticamente aceitável e um de: um agente antitumoral de plantina e um taxano, composição farmacêutica, produto de combinação, kit, e, método para a produção de um efeito de danificação vascular em um animal de sangue quente
CY1107819T1 (el) Φαρμακευτικη διαμορφωση της ολανζαπινης
JP2014162725A (ja) 外用組成物
ATE382356T1 (de) Pharmazeutische zusammensetzung enthaltend estetrolderivate und anwendung in der krebsbehandlung
BR0309057A (pt) Formulações lìquidas com baixa dosagem em entecavir e uso
BR0115518A (pt) Kit de repinotan
SG152257A1 (en) Topical preparation containing ambroxol
PT1635852E (pt) ''utilização de composições para reconstituição de unhas para aplicação tópica em onicosquise''
ATE303137T1 (de) Pharmazeutische zusammensetzung zur orale verabreichung mit verbesserter bioverfügbarkeit
HRP20050787A2 (en) Pharmaceutical composition comprising 5-methyl-2-2'-(chloro-6'-fluoroanilino) phenylacetic acid
BR0206979A (pt) Métodos e composições para reduzir o paladar de agentes farmaceuticamente ativos
HRP20100208T1 (hr) Postupak liječenja akutnog rinosinusitisa
CL2025000209A1 (es) Formulación farmacéutica estable líquida oral de un agente antiespasmódico
MX2008001532A (es) Composicion farmaceutica que contiene indometacina y/o acemetacina.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]